Guidance
Company raised 2025 adjusted EBITDA guidance by $450 million
Guidance · revenue to $75.75B
← 피드로 돌아가기
01
02
03
04
AI
수요
자본지출
HCA
FY2025 Q3
RAISED
HCA Healthcare, Inc. 실적 발표
Buzzberg 분석
Company raised 2025 adjusted EBITDA guidance by $450 million
HCA reported strong Q3 2025 results with 42% adjusted EPS growth and raised full-year guidance. Management cited broad-based volume growth, improved payer mix, and significant Medicaid supplemental payment benefits. They expressed confidence in 2026 demand within the 2-3% volume growth range while noting uncertainty around federal enhanced premium tax credits. Operational efficiencies and a robust resiliency program continue to support margin expansion. Revenue increased 9.6% in Q3; adjusted EBITDA raised $450M at midpoint for FY2025, split between $250M from supplemental payments and $200M from operations.
Buzzberg 분석 Company raised 2025 adjusted EBITDA guidance by $450 million HCA reported strong Q3 2025 results with 42% adjusted EPS growth and raised full-year guidance. Management cited broad-based volume growth, improved payer mix, and significant Medicaid supplemental payment benefits. They expressed confidence in 2026 demand within the 2-3% volume growth range while noting uncertainty around federal enhanced premium tax credits. Operational efficiencies and a robust resiliency program continue to support margin expansion. Revenue increased 9.6% in Q3; adjusted EBITDA raised $450M at midpoint for FY2025, split between $250M from supplemental payments and $200M from operations. 전체 분석 보기분석 접기
HCA reported strong Q3 2025 results with 42% adjusted EPS growth and raised full-year guidance. Management cited broad-based volume growth, improved payer mix, and significant Medicaid supplemental payment benefits. They expressed confidence in 2026 demand within the 2-3% volume growth range while noting uncertainty around federal enhanced premium tax credits. Operational efficiencies and a robust resiliency program continue to support margin expansion. Revenue increased 9.6% in Q3; adjusted EBITDA raised $450M at midpoint for FY2025, split between $250M from supplemental payments and $200M from operations.
- Same-facility equivalent admissions grew 2.4%; commercial admissions up 3.7%, Medicare up 3.4%; ER visits up 1.3% despite a slow respiratory season.
- Medicaid supplemental payment net benefit in Q3 was $240M higher YoY, driven by Tennessee, Kansas, and Texas approvals; FY2025 guide includes $250-350M net benefit improvement.
- Hurricane-impacted markets (North Carolina) are still recovering; FY2025 expected to recapture $100M of the $250M EBITDA hit from 2024, with most in Q4.
Revenue
$19.161B
reported
EPS
$6.96
reported
Gross margin
41.83%
reported
Op margin
15.47%
reported
이번 분기에 달라진 점
Demand
Expects health services volumes within long-term 2-3% growth range
Management expressed confidence in the company's positioning, citing strong operational performance, diversified portfolio, and ongoing investments in resiliency and technology.
Margins
Resiliency program enhanced and accelerated for future
Reported gross margin was 41.83%, reinforcing the quarter's better-than-guided profitability.
Demand
Medicare Advantage volumes up 4.8% year-over-year
Expects health services volumes within long-term 2-3% growth range. Management expressed confidence in the company's positioning, citing strong operational performance, diversified portfolio, and ongoing investments in resiliency and technology.
AI, 자본지출 및 수요 분석
플랫폼 및 수익화
Management discussed the use of AI and digital tools in revenue cycle management, focusing on responding to payer denials, and noted piloting ambient AI documentation tools for physicians.
수주 및 전환
Expects health services volumes within long-term 2-3% growth range. Management expressed confidence in the company's positioning, citing strong operational performance, diversified portfolio, and ongoing investments in resiliency and technology.
투자 및 생산능력
Capital expenditures for 2025 are expected to be approximately $5 billion. Management indicated more capital is coming online in 2026, which will add physical capacity and align with workforce capacity to accommodate anticipated demand.
톤 · Confident
Management expressed confidence in the company's positioning, citing strong operational performance, diversified portfolio, and ongoing investments in resiliency and technology.
향후 가이던스
RaisedGuidance · revenue to $75.75B
| 지표 | 기간 | 범위 | 중간값 | 상태 |
|---|---|---|---|---|
| Capex | FY2025 | $5B | $5B | MAINTAINED |
| EPS | FY2025 | $27.00–$28.00 | $27.50 | RAISED |
| Op margin | FY2025 | $15.25B–$15.65B | $15.45B | RAISED |
| Revenue | FY2025 | $75B–$76.5B | $75.75B | RAISED |
가이던스 신뢰도
100%과거 적중률
100%
Mike Marks
1 of 1 · 평균 편향 -2.0%